 Intellia Therapeutics, Inc. NASDAQ:NTLA Q2 2022 Results Earnings Conference Call August 4, 2022 8:00 AM ET Company Participants Ian Karp - Senior Vice President , Investor Relations and Corporate Communications John Leonard - President and Chief Executive Officer David Lebwohl - Executive Vice President and Chief Medical Officer Laura Sepp-Lorenzino - Executive Vice President and Chief Scientific Officer Glenn Goddard - Executive Vice President and Chief Financial Officer Conference Call Participants Joon Lee - Truist Securities Maury Raycroft - Jefferies Dae Gon Ha - Stifel Gena Wang - Barclays Joseph Thome - Cowen and Company Swapnil Malekar - Piper Sandler Salveen Richter - Goldman Sachs Luca Issi - RBC Capital Markets Richard Law - Credit Suisse Greg Harrison - Bank of America Mani Foroohar - SVB Leerink Jay Olson - Oppenheimer Co. Ry Forseth - Guggenheim Partners Kostas Biliouris - BMO Capital Markets Yanan Zhu - Wells Fargo Operator Good morning. And welcome to the Intellia Therapeutics Second Quarter 2022 Financial Results Conference Call. 